Recurrent Squamous Cell Carcinoma of the Head or Neck
Also known as: Recurrent Head and Neck Squamous Cell Cancer / Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Recurrent Head and Neck Squamous Cell Carcinoma / Recurrent Squamous Cell Carcinoma of the Head and Neck
Drug | Drug Name | Drug Description |
---|---|---|
DB00002 | Cetuximab | An endothelial growth factor receptor binding fragment used to treat colorectal cancer as well as squamous cell carcinoma of the head and neck. |
DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |